Hedge Fund - Bridger Management
Alnylam Pharmaceuticals Inc. (ALNY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $9,443,950 | 4.69% | 34,975 | $257.00 |
| 2 | 2024 - Q4 (2024-12-31) | $9,690,536 | 5.2% | 41,182 | $262.99 |
| 3 | 2024 - Q3 (2024-09-30) | $10,182,161 | 5.09% | 37,022 | $260.36 |
| 4 | 2024 - Q2 (2024-06-30) | $8,996,346 | 4.62% | 37,022 | $157.87 |
| 5 | 2024 - Q1 (2024-03-31) | $7,909,193 | 3.56% | 52,922 | $166.82 |
| 6 | 2023 - Q4 (2023-12-31) | $3,621,860 | 1.38% | 18,922 | $170.34 |
| 7 | 2021 - Q4 (2021-12-31) | $0 | 0% | 0 | $185.86 |
| 8 | 2021 - Q3 (2021-09-30) | $11,292,000 | 1.32% | 59,804 | $187.58 |
| 9 | 2021 - Q2 (2021-06-30) | $18,868,000 | 1.76% | 111,304 | $146.46 |
| 10 | 2021 - Q1 (2021-03-31) | $31,980,000 | 2.98% | 226,504 | $150.49 |
| 11 | 2020 - Q4 (2020-12-31) | $40,763,000 | 3.1% | 313,632 | $133.53 |
| 12 | 2020 - Q3 (2020-09-30) | $52,304,000 | 4.18% | 359,234 | $142.11 |
| 13 | 2020 - Q2 (2020-06-30) | $53,206,000 | 4.92% | 359,234 | $134.81 |
| 14 | 2020 - Q1 (2020-03-31) | $37,833,000 | 4.37% | 347,573 | $115.43 |
| 15 | 2019 - Q4 (2019-12-31) | $53,890,000 | 3.88% | 467,918 | $99.70 |
| 16 | 2019 - Q3 (2019-09-30) | $28,289,000 | 2.33% | 351,761 | $79.11 |
| 17 | 2019 - Q2 (2019-06-30) | $45,475,000 | 3.56% | 626,716 | $76.72 |
| 18 | 2019 - Q1 (2019-03-31) | $58,168,000 | 4.6% | 622,450 | $83.64 |
| 19 | 2018 - Q4 (2018-12-31) | $48,032,000 | 4% | 658,785 | $76.92 |
| 20 | 2018 - Q3 (2018-09-30) | $63,278,000 | 3.66% | 723,010 | $100.59 |
| 21 | 2018 - Q2 (2018-06-30) | $63,276,000 | 3.42% | 642,466 | $99.19 |
| 22 | 2018 - Q1 (2018-03-31) | $65,461,000 | 3.97% | 549,632 | $128.92 |
| 23 | 2017 - Q4 (2017-12-31) | $63,553,000 | 4.19% | 500,219 | $125.65 |
| 24 | 2017 - Q3 (2017-09-30) | $45,108,000 | 2.7% | 383,933 | $85.36 |
| 25 | 2017 - Q2 (2017-06-30) | $60,548,000 | 3.45% | 759,127 | $63.91 |
| 26 | 2017 - Q1 (2017-03-31) | $37,263,000 | 2.12% | 727,091 | $46.22 |
| 27 | 2016 - Q4 (2016-12-31) | $26,905,000 | 1.87% | 718,615 | $41.87 |
| 28 | 2016 - Q3 (2016-09-30) | $66,630,000 | 4.48% | 983,040 | $70.55 |
| 29 | 2016 - Q2 (2016-06-30) | $38,122,000 | 2.46% | 687,009 | $63.00 |
| 30 | 2016 - Q1 (2016-03-31) | $50,041,000 | 3.45% | 797,212 | $66.49 |
| 31 | 2015 - Q4 (2015-12-31) | $67,547,000 | 2.23% | 717,521 | $92.72 |
| 32 | 2015 - Q3 (2015-09-30) | $57,248,000 | 3.9% | 712,389 | $111.10 |
| 33 | 2015 - Q2 (2015-06-30) | $74,784,000 | 2.36% | 623,880 | $119.50 |
| 34 | 2015 - Q1 (2015-03-31) | $65,446,000 | 4.37% | 626,758 | $101.34 |
| 35 | 2014 - Q4 (2014-12-31) | $54,751,000 | 3.44% | 564,439 | $92.65 |
| 36 | 2014 - Q3 (2014-09-30) | $57,926,000 | 3.94% | 741,688 | $64.51 |
| 37 | 2014 - Q2 (2014-06-30) | $31,585,000 | 2.22% | 500,000 | $59.44 |
| 38 | 2014 - Q1 (2014-03-31) | $29,542,000 | 1.97% | 440,000 | $77.42 |
| 39 | 2013 - Q4 (2013-12-31) | $28,292,000 | 1.97% | 440,000 | $59.65 |
| 40 | 2013 - Q3 (2013-09-30) | $28,368,000 | 2.03% | 443,181 | $49.85 |
| 41 | 2013 - Q2 (2013-06-30) | $31,826,000 | 2.33% | 1,026,648 | $26.61 |
| 42 | 2013 - Q1 (2013-03-31) | $33,305,000 | 2.3% | 1,366,648 | $23.34 |
| 43 | 2012 - Q4 (2012-12-31) | $36,010,000 | 2.56% | 1,973,155 | $17.32 |
| 44 | 2012 - Q3 (2012-09-30) | $30,398,000 | 2.18% | 1,617,800 | $17.78 |
The displayed share prices are average quarterly stock market prices.